HNN3.0
Register
Register
Register

Project cooperationUpdated on 16 January 2026

Participation in consortia with public funding

Director Processes & Innovation at RISE - Research Institutes of Sweden

Södertälje, Sweden

About

RISE has extensive experience as a partner (or even coordinator) in publicly funded projects and are interested to participate in new applications. RISE departments are always interested to discuss public funding.

Here are some relevant examples for the Life Science field:

RISE is Sweden’s research institute and innovation partner. Through our international collaboration programs with industry, academia and the public sector, we ensure the competitiveness of the Swedish business community on an international level and contribute to a sustainable society. Our 3000+ employees engage in and support all types of innovation processes. RISE is an independent, State-owned research institute, which offers unique expertise and over 100 testbeds and demonstration environments for future-proof technologies, products and services.

For Life Science projects, we can contribute with the following:

  • Medical device development

  • Calculations, predictions and assessments of chemicals and processes

  • Multi-omic analyses

  • In vitro and bioanalysis studies

  • Ex vivo, tissue engineering and bioprinting

  • Pharmaceutical development

  • Formulation of biopharmaceuticals, small molecules and various other materials

  • (Green) chemical process development and optimization

  • Chemical analysis, characterization and stability studies

  • Technical system design/Architecture prototype implementation

  • Quality-assurance of measurement tools

  • Social Outcomes Contracting

  • Health data platforms

  • Implementation of digital solutions and new ways of working

Organisation

RISE - Research Institutes of Sweden

R&D Institution

Södertälje, Sweden

Similar opportunities

  • Project cooperation

    LNP delivery with barcoded mRNA

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)

    Filip Van Nieuwerburgh

    Professor at Ghent University

    Ghent, Belgium

  • Project cooperation

    Looking for collaborations in CL1

    • Partner seeks Consortium/Coordinator
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people

    Lorena Montesino Redondo

    European Proposals Specialist at ITENE Research Centre

    Valencia, Spain

  • Project cooperation

    Development of a vaccine against Tick-borne encephalitis virus

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential

    Benjamin DAMIEN

    CEO at SAGITTA BIOTECH

    Liège, Belgium